BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 17, 2026
Breaking News: Viva in vivo! At EHA, in vivo CAR T data continues to impressBreaking News: Ongoing coverage of the Ebola outbreak
Home » Topics » BioWorld Asia

BioWorld Asia
BioWorld Asia RSS Feed RSS

Blue heart and data grid

Ji Xing acquires rights to heart failure treatment from Cytokinetics in $400M deal

Dec. 28, 2021
By Doris Yu
RTW Investments LP-backed Ji Xing Pharmaceuticals Ltd. has acquired greater China rights to Cytokinetics Inc.’s omecamtiv mecarbil in a deal worth up to $400 million.
Read More
Concept of business partnership

ITM is made in China with potential $589M+ radiopharmaceutical deal

Dec. 28, 2021
By Cormac Sheridan
DUBLIN – ITM Isotope Technologies Munich (ITM) SE has secured its first radiopharmaceutical licensing deal in China, a pact with Grand Pharmaceutical Group Ltd. involving two radiopharmaceutical candidates, as well as a companion diagnostic for one of them.
Read More
Antibodies attacking cancer cell

Legochem licenses out ADC to Iksuda in $1B deal

Dec. 28, 2021
By Gina Lee
Legochem Biosciences Inc. has licensed out its antibody-drug conjugate (ADC) LCB-14 to Iksuda Therapeutics Ltd. in the duo’s latest deal that is worth $1 billion. Daejeon, South Korea-based Legochem will receive $50 million in an up-front payment and near-term milestones, and up to $950 million in developments, regulatory and commercial milestones.
Read More

Regulatory actions for Dec. 21-27, 2021

Dec. 28, 2021
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Bioartic, Biogen, Biontech, Cstone, Daiichi Sankyo, Eirgenix, Eisai, Everest, Gilead, I-Mab, Innovent, Lianbio, Lion TCR, Merck, Moderna, Novavax, Pfizer, Providence, Sandoz, Takeda, Telix, Vaxine, Zogenix.
Read More

Other news to note for Dec. 28, 2021

Dec. 28, 2021
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Aerogen, Affiris, Astrazeneca, Basilea, Biondvax, Chemrar, Claritas, Cocrystal, Cyrus, Enzene, Frontier, FS Development, Hemogenyx, Merck, Neurocrine, Nuance, Pardes, Pfizer, Piramal, Rapid Dose, RDIF, Replicel Life Sciences, Ridgeback, Salzman Group, Shiseido, Sosei, Sutro, Tasly, Theramex, Westvac, Wuxi Apptec, Yapan.
Read More

In the clinic for Dec. 21-27, 2021

Dec. 28, 2021
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akston, Alphamab, Antengene, Henlius, Kissei, Mereo, Novavax, Rigel, Statera, Sumitomo Dainippon, Telix, Urovant.
Read More

Financings for Dec. 28, 2021

Dec. 28, 2021
Biopharmas in Asia-Pacific raising money in public or private financings: Northview Acquisition.
Read More

Appointments and advancements for Dec. 28, 2021

Dec. 28, 2021
New hires and promotions in the biopharma industry in Asia-Pacific, including: Shouti, Zai Lab.
Read More

Regulatory actions for Dec. 14-20, 2021

Dec. 21, 2021
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Alterity, Antengene, Astellas, Astrazeneca, Beigene, Biogen, Daiichi Sankyo, Eisai, Enlivex, Everest, Glaxosmithkline, I-Mab, J&J, Karyopharm, Laurent, Medicago, Moderna, Novavax, Paratek, Pfizer, Seagen, Senhwa, Sobi, Takeda, Tonix, Vir, Zai.
Read More

Other news to note for Dec. 21, 2021

Dec. 21, 2021
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Antengene, Astrazeneca, Atea, Beigene, Biomarin, Biontech, Cadila, Cytokinetics, Eisai, Gilead, Iktos, Ji Xing, Lipidor, Mesoblast, Moderna, Nanjing Leads Biolabs, Nference, Noorik, Novartis, Numab, Ocugen, Oragenics, Paratek, Pfizer, Providence, RDIF, SAB, Samsung Biologics, Sirona, Skyline, Sosei, Sunshine Guojian, Twist, Tyme, Vaxart, Vaxthera, Xtalpi, Zai.
Read More
Previous 1 2 … 301 302 303 304 305 306 307 308 309 … 1489 1490 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 16, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Medical illustration showing layers of a blood vessel

    Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis

    BioWorld Science
    More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
  • Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs

    BioWorld Science
    Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing